What exactly did Piper Sandler change for Colgate-Palmolive?

Piper Sandler on January 30, 2026 maintained an **Overweight** rating for Colgate-Palmolive and raised the price target to **$96** from **$88**, according to TheFly. This is a positive analyst signal for investors monitoring CL analyst rating

How should investors interpret an Overweight from Piper Sandler?

Overweight means the analyst expects CL to outperform its sector over 12 months. It is a relative view, not a guarantee, and investors should weigh valuation, dividend yield, and company catalysts before acting

Does the new price target change the consensus?

Piper Sandler’s **$96** target sits above the consensus average near **$90.67**, nudging the mean higher. The move modestly shifts expectations but does not dramatically alter the broader analyst landscape

What does Meyka AI say about CL after this rating?

Meyka AI rates CL with a **B+**, reflecting benchmark, sector, growth, metrics, and analyst consensus. The grade supports a constructive stance but is not financial advice

Analyst Ratings

Piper Sandler Maintains Overweight for Colgate-Palmolive (CL) Jan 30, 2026

ByHuzaifa Zahoor February 2, 2026

Piper Sandler maintained an Overweight rating on Colgate-Palmolive Company (CL) on January 30, 2026, and raised its price target to $96 from $88. The note moved the stock about 1.05% ($0.94) since publication and reflects confidence in near-term margin recovery. This CL analyst rating update signals that Piper Sandler expects Colgate to outperform peers and supports the recent consensus view on the stock